Chimeric antigen receptors that bind to SSEA4 and uses thereof
An isolated nucleic acid that contains a nucleotide sequence that encodes the polypeptide of SEQ ID NO: 3. The polypeptide of SEQ ID NO: 3 specifically binds to stage-specific embryonic antigen 4 (SSEA4). Also disclosed is a recombinant cell comprising the isolated nucleic acid described above, a viral vector containing the above isolated nucleic acid, and an isolated polypeptide including the sequence of SEQ ID NO: 3. Provided as well is a chimeric antigen receptor (CAR) that includes a single chain Fv having the sequence of SEQ ID NO: 3 and specifically binding to SSEA4. Moreover, a method is disclosed for treating a tumor by transducing in vitro the T cells of a subject having a tumor expressing SSEA4 with a vector that encodes the CAR, expanding the transduced T cells, and infusing the expanded transduced T cells into the subject, whereby an anti-tumor T cell response is raised.
1. An isolated polypeptide comprising the sequence of SEQ ID NO: 3, wherein the isolated polypeptide specifically binds to stage-specific embryonic antigen 4.
2. A chimeric antigen receptor, comprising a single chain Fv (scFv) that specifically binds to stage-specific embryonic antigen 4, and a first endodomain from CD3ζ or FccRIγ, wherein the scFv has the sequence of SEQ ID NO: 3.
3. The chimeric antigen receptor of claim 2 , further comprising a second endodomain from CD28, CD137, CD4, OX40, or ICOS, wherein the scFv is fused to the second endodomain and the second endodomain is fused to the first endodomain.
4. The chimeric antigen receptor of claim 3 , wherein the chimeric antigen receptor has the sequence of SEQ ID NO: 4.
5. The chimeric antigen receptor of claim 3 , further comprising an epidermal growth factor receptor t domain III-IV at its C-terminus.
6. The chimeric antigen receptor of claim 5 , wherein the chimeric antigen receptor has the sequence of SEQ ID NO: 2.